Prof. Dr. Bernhard Hauer was born in Bretten in 1955. After studying biology at the University of Hohenheim, he took his doctorate at the Institute of Microbiology under Prof. F. Lingens. He then worked as a postdoctoral fellow at the University of Chicago, before joining BASF, Ludwigshafen, as a scientist in 1983, where he established the biocatalysts business and was eventually appointed Vice President. At the same time, he was active at the University of Heidelberg where he took his postdoctoral qualification in molecular biology. In 2009, he became head of the Institute of Biochemistry and Technical Biochemistry at the University of Stuttgart. His research focuses on the development of enzymes for non-physiological reactions and the development of new biosynthetic pathways. This work opens up access to new chemical products and materials. Besides his work as a university professor, Prof. Dr. Hauer is a member of the scientific advisory boards of Biosyntia ApS, Provivi, Inc. and Arzeda Corporation.
Prof. Dr. Hauer has been a member of the Supervisory Board since 07.03.2019 and is elected until the end of the AGM in FY 2022/23.
Further memberships of statutory supervisory boards in Germany:
Further memberships in comparable German and foreign supervisory boards:
Independent within the meaning of Section 5.4.2 of the German Corporate Governance Code:
Last update: September 2019